| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.12 | 5e-05 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.23 | 5e-05 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.22 | 7e-05 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.14 | 8e-05 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 8e-05 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |